BCN Biosciences LLC - Company Review
BCN Biosciences LLC - Company ReviewSummary
BCN Biosciences LLC (BCN Biosciences) is a preclinical biotechnology company that concentrates on the oncology drug discovery and development market. The company’s product candidates include BCN303, a lead monoclonal antibody developed against gene targets that affect breast and colon cancer; and BCN057, a novel small molecule drug that protect normal tissue against radiation damage. BCN Biosciences’ product portfolio also includes other assets such as BCN112 to address lung cancer indications. The company partners with universities, industry partners and government authorities to develop drugs that counter acute radiation syndrome. It develops and commercializes both small molecule and biological therapeutic candidates. BCN Biosciences is headquartered in Inglewood, California, the US.
This comprehensive company report of BCN Biosciences LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.